Dr. Abdullah Fayez AlAsmari | د. عبدالله بن فايز الأسمري

Dr. Abdullah AlAsmari graduated from King Saud University (KSU) with a bachelor of Sciences in Pharmaceutical Sciences in 2011 with second class of honor. After that, he joined the Saudi Food and Drug Authority (SFDA) in 2011 as a senior pharmacist in the executive directorate of pharmacovigilance and crisis management. During his work in the SFDA, Dr. AlAsmari was a member and a coordinator of different committees and attended many conferences and workshops locally and globally. After that, Dr. AlAsamri joined  as a teaching assistant.
In 2013, Dr. AlAsmari joined Auburn University (AU), Harrison School of Pharmacy (HSOP) to pursue his PhD. During his graduate studies, Dr. AlAsmari focused on investigating novel molecular signaling mechanisms that can protect the heart from damage against IR injury. During his studies at AU, he was chosen by the graduate school of Auburn University to be a judge in the research judging committee. Also, he was awarded the second place of best scientific poster presentation at Auburn University Research Week symposium during his first year at Auburn University. Furthermore, he received a travel award from the graduate school of Auburn University.
In 2017, Dr. AlAsmari was awarded a Doctor of Philosophy degree (PhD) in Pharmaceutical Sciences from Auburn University and became an assistant professor in the department of Pharmacology \& Toxicology at KSU. Currently, Dr. AlAsmari is an Associate Professor and the Vice Dean of Graduate School for Programs and Initiatives and a member and chairman of different standing committee inside and outside KSU. Also, Dr. AlAsamri is a member in different committees related to the Saudi Pharmacist Licensure Examination  (SPLE). Dr. AlAsmari is working on different funded projects, which aim to induce cardioprotection against different mechanisms that can induce cardiac damage. Since 2017, Dr. AlAsmari has authored and co-authored over 100 peer-reviewed articles and book chapters, and supervised and co-supervised number of graduate students. In addition, he is a reviewer and guest editor for many reputable journals and a member of different scientific societies. His research area includes:

• Cardiovascular Diseases (Ischemic Heart Diseases)

• Ischemia Reperfusion (IR) Injury

• Myocardial Bioenergetics

• Mitochondrial proteins and its role during IR injury

• Hypoxia Inducible Factor-1 (HIF-1a)

• Purinergic Signaling

• Molecular signaling mechanisms in diabetic and hyperglycemic models

• Mechanisms of cardiotoxicity induced by different anti-cancer drugs